Publication & Citation Trends
Most Cited Works
Publications
46 total
AB-101, an allogeneic, non–genetically modified, natural killer (NK) cell therapy, evaluated as monotherapy or in combination with rituximab in R/R non-Hodgkin lymphoma.
Cited by 2
Semantic Scholar
Trial in Progress: AB-101, an Allogeneic, Non-Engineered, Cord Blood-Derived Natural Killer (NK) Cell Therapy, As Monotherapy or in Combination with Rituximab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma OA
Cited by 1
Semantic Scholar
Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth <i>In Vitro</i> and <i>In Vivo</i> PDF
Cited by 147
OpenAlex
Cobomarsen, an oligonucleotide inhibitor of miR‐155, co‐ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T‐cell lymphoma PDF
Cited by 304
OpenAlex
A MicroRNA-29 Mimic (Remlarsen) Represses Extracellular Matrix Expression and Fibroplasia in the Skin
Cited by 271
OpenAlex
Ph 1 study of MRG-106, an inhibitor of miR-155, in CTCL.
Cited by 16
Semantic Scholar
Restoring miRNAs of the miR-183/96/182 cluster results in target gene regulation and ameliorates symptoms of retinal degeneration in a mouse model of retinitis pigmentosa
Cited by 0
Semantic Scholar
A Template-proximal RNA Paired Element Contributes to S. cerevisiae Telomerase Activity
Cited by 0
Semantic Scholar
Research Topics
MicroRNA in disease regulation
(21)
RNA Interference and Gene Delivery
(12)
Circular RNAs in diseases
(7)
Protein Degradation and Inhibitors
(7)
RNA Research and Splicing
(6)
Frequent Co-Authors
Affiliations
Howard Hughes Medical Institute
University of Miami
University of California, San Francisco
King's College London
University of Colorado Boulder